Chapter 14. Botulinum Toxin for Treatment of Dystonia

  1. Mark Hallett2 and
  2. Werner Poewe3
  1. Dirk Dressler

Published Online: 29 OCT 2008

DOI: 10.1002/9780470713990.ch14

Therapeutics of Parkinson's Disease and Other Movement Disorders

Therapeutics of Parkinson's Disease and Other Movement Disorders

How to Cite

Dressler, D. (2008) Botulinum Toxin for Treatment of Dystonia, in Therapeutics of Parkinson's Disease and Other Movement Disorders (eds M. Hallett and W. Poewe), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470713990.ch14

Editor Information

  1. 2

    Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA

  2. 3

    Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria

Author Information

  1. Department of Neurology, Hannover Medical School, Hannover, Germany

Publication History

  1. Published Online: 29 OCT 2008
  2. Published Print: 17 OCT 2008

ISBN Information

Print ISBN: 9780470066485

Online ISBN: 9780470713990

SEARCH

Keywords:

  • dystonia;
  • botulinum toxin;
  • pharmacology;
  • basic principles;
  • indications

Summary

This chapter contains sections titled:

  • History

  • Pharmacology of Botulinum Toxin Drugs

  • Basic Principles of Botulinum Toxin Therapy

  • Specific Indications for Botulinum Toxin Therapy in Dystonia

  • Outlook

  • References